Global Biomarkers Market Growth (Status and Outlook) 2024-2030
Biomarkers market expands from US$61.57 billion in 2023 to US$165.24 billion by 2030, with a 15.1% CAGR, due to growing demand in the downstream market.
If you purchase this report now and we update it in next 100 days, get it free!
The human body is a complex biological system, and within it lies a treasure trove of information about our health. Biomarkers, acting as biological indicators, offer us a window into these secrets. They can be molecules, genes, proteins, or even cellular processes that provide valuable insights into our health status. Biomarkers can reveal the presence of a disease, its stage of progression, how well a patient might respond to a particular treatment, and even an individual's susceptibility to certain illnesses. For instance, a genetic biomarker might indicate a person's predisposition to developing a specific type of cancer, while a protein biomarker could signal the presence of inflammation in the body, potentially linked to an autoimmune disease. By analyzing these biological markers, healthcare professionals gain a deeper understanding of the underlying biological processes at play, allowing for a more informed approach to diagnosis, treatment, and preventive measures.
According to our publisher’s latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period.
The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biomarkers. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biomarkers market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
Key Features:
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
The report on Biomarkers market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biomarkers market. It may include historical data, market segmentation by Type (e.g., Sepsis Biomarkers, Antibiotic Resistance Biomarkers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biomarkers market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Market Drivers:
• Rising prevalence of chronic diseases like cancer and diabetes fuels demand for improved diagnostics and personalized medicine.
• Growing investments in drug discovery and development necessitate reliable biomarkers to assess drug efficacy and safety.
Market Challenges:
• Stringent regulatory requirements for biomarker development and validation can hinder market growth.
• High costs associated with biomarker development and implementation can limit accessibility.
Market Trends:
• Focus on developing companion diagnostics alongside new drugs for targeted treatment approaches.
• Increasing adoption of non-invasive and liquid biopsy techniques for easier biomarker testing.
• Growing interest in artificial intelligence and machine learning for biomarker data analysis and personalized medicine.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biomarkers market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biomarkers industry. This include advancements in Biomarkers technology, Biomarkers new entrants, Biomarkers new investment, and other innovations that are shaping the future of Biomarkers.
• Liquid Biopsies: Minimally invasive analysis of biomarkers in fluids for disease detection.
• Omics Technologies: Comprehensive biomarker identification using genomics, proteomics, and metabolomics.
• AI & Machine Learning: Data analysis for biomarker discovery and improved diagnostics.
• Point-of-Care Testing: Faster and easier diagnosis with portable biomarker detection devices.
• Biomarker Imaging: Combining imaging techniques with biomarker analysis for deeper insights.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biomarkers market. It includes factors influencing customer ' purchasing decisions, preferences for Biomarkers product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biomarkers market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biomarkers market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biomarkers market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biomarkers industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
• Personalized Medicine: The rise of personalized medicine, where treatments are tailored to individual patients, necessitates the use of biomarkers to identify disease risks, predict treatment responses, and monitor disease progression.
• Early Disease Detection: Biomarkers hold immense potential for early disease detection, enabling intervention at earlier stages when treatment is more effective. This can significantly improve patient outcomes and reduce healthcare costs.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biomarkers market.
• Precision Medicine: The rise of personalized medicine approaches that tailor treatments to individual patients creates a strong demand for biomarkers to identify disease susceptibility, predict treatment response, and monitor therapy effectiveness.
• Early Disease Detection: Biomarkers hold immense potential for earlier and more accurate disease detection, leading to better patient outcomes and reduced healthcare costs.
Market Segmentation:
Biomarkers market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Segmentation by application
Diagnostics
Drug Discovery
Personalized Medicine
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biomarkers Market Size 2019-2030
2.1.2 Biomarkers Market Size CAGR by Region 2019 VS 2023 VS 2030
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More